Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Total Current Liabilities Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Total Current Liabilities
$119m
CAGR 3-Years
5%
CAGR 5-Years
79%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Total Current Liabilities
CA$7.6m
CAGR 3-Years
23%
CAGR 5-Years
92%
CAGR 10-Years
32%
Replicel Life Sciences Inc
XTSX:RP
Total Current Liabilities
CA$1.5m
CAGR 3-Years
-18%
CAGR 5-Years
-5%
CAGR 10-Years
15%
Innovotech Inc
XTSX:IOT
Total Current Liabilities
CA$171.1k
CAGR 3-Years
21%
CAGR 5-Years
0%
CAGR 10-Years
-13%

See Also

What is Abcellera Biologics Inc's Total Current Liabilities?
Total Current Liabilities
119m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Total Current Liabilities amounts to 119m USD.

What is Abcellera Biologics Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
79%

Over the last year, the Total Current Liabilities growth was 1%. The average annual Total Current Liabilities growth rates for Abcellera Biologics Inc have been 5% over the past three years , 79% over the past five years .

Back to Top